Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy : VinoMetro

Krajnak, SlavomirDecker, ThomasSchollenberger, LukasRosé, ChristianRuckes, ChristianFehm, TanjaThomssen, CristophHarbeck, NadiaSchmidt, Marcus2022-08-152022-08-152021https://openscience.ub.uni-mainz.de/handle/20.500.12030/7565engCC-BY-4.0https://creativecommons.org/licenses/by/4.0/610 Medizin610 Medical sciencesPhase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy : VinoMetro—AGO-B-046Zeitschriftenaufsatz